CLEAR CELL RENAL CARCINOMA
Tracking # 20-813085
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
AMONG THE GENITOURINARY CANCERS, RENAL CELL CARCINOMA (RCC) IS THE SEVENTH MOST COMMON CANCER IN MEN AND HAS A HIGH MORTALITY RATE. THE PROGNOSIS OF METASTATIC RCC IS POOR, WITH A MEDIAN SURVIVAL OF ABOUT 13 MONTHS AND 5-YEAR SURVIVAL UNDER 10%. HOWEVER, WITH NEWER THERAPIES, OVERALL SURVIVAL HAS IMPROVED. THIS ACTIVITY REVIEWS THE EVALUATION AND TREATMENT OF CLEAR CELL RENAL CELL CARCINOMA AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN EVALUATING AND TREATING THIS CONDITION.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1h
AMA Category I
Physician Assistant
1h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1h
AMA Category I